Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers

Lung Cancer

Volumn 32, Issue 3, 2001, Pages 289-295

  Gemma, Akihiko ^a   Hosoya, Yoko ^a   Seike, Masahiro ^a   Uematsu, Kazutsugu ^a   Kurimoto, Futoshi ^a   Hibino, Suguru ^a   Yoshimura, Akinobu ^a   Shibuya, Masahiko ^a   Kudoh, Shoji ^a   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Genomic structure; Human MAD2 gene; Lung cancer; Mutation polymorphism

Indexed keywords

ANEUPLOIDY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; GENE EXPRESSION REGULATION; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; CELL CYCLE PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FUNGAL PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0034997386     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00223-3     Document Type: Article

References (23)

1. Mitelman F., Johansson B., Mertens F. Catalog of Chromosome Aberrations in Cancer. 2:1994;Wiley-Liss, New York.
2. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
3. Murray A.W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5:1995;5-11.
4. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science. 274:1996;1664-1672.
5. Nasmyth K. At the heart of the budding yeast cell cycle. Trends Genet. 12:1996;405-412.
6. Paulovich A.G., Toczyski D.P., Hartwell L.H. When checkpoints fail. Cell. 88:1997;315-321.
7. Cahill D.P., Lengauer C., Yu J., et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
8. Gemma A., Seike M., Seike Y., et al. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer. 29:2000;213-218.
9. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science. 274:1996;246-248.
10. Bloendal T., Lindgram A. Fluorescence cytophotometric measurement of nuclear DNA in adenocarcinoma of the lung: relation of proliferative activity and DNA ploidy to prognosis. Ann. Quant. Cytol. 4:1982;225-232.
11. Asamura H., Nakajima T., Mukai K., Shimosato Y. Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence. Chest. 96:1989;312-318.
12. Cibas E.S., Melamed M.R., Zaman M.B., Kimmel M. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer. 63:1989;1552-1556.
13. Van Bodegom P.C., Baak J.P.A., Galen C.S., et al. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage I resected squamous cell lung cancer and long term follow up. Cancer. 63:1989;143-147.
14. Gemma A., Hisakatu S., Yamano Y., et al. Significance of nuclear DNA content analysis in advanced lung cancer using transbronchial biopsy samples. J. Jpn. Soc. Clin. Cytol. 32:(6):1993;840-845.
15. Takahashi T., Haruki N., Nomoto S., et al. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene. 18:1999;4295-4300.
16. Gemma A., Hagiwara K., Ke Y., et al. FHIT mutations in human primary gastric cancer. Cancer Res. 57:1997;1435-1437.
17. Gemma A., Hagiwara K., Vincent F., et al. hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors. Oncogene. 16:1998;951-956.
18. Hagiwara K., Harris C.C. 'Long distance sequencer method': a novel strategy for large DNA sequencing projects. Nucleic Acids Res. 24:1996;2460-2461.
19. Gemma A., Takenoshita S., Hagiwara K., et al. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4B/MTS2, p16 INK4/MTS1, p18 and p19 in human cancer cell lines. Int. J. Cancer. 68:1996;605-611.
20. Taniguchi Y., Gemma A., Takeda Y., et al. Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy. Lung Cancer. 14:1996;219-228.
21. Cahill D.P., da Costa L.T., Carson-Walter E.B., Kinzler K.W., Vogelstein B., Lengauer C. Characterization of MAD2B and other mitotic spindle checkpoint genes. Genomics. 58:1999;181-187.
22. Weitzel D.H., Vandre D.D. Differential spindle assembly checkpoint response in human lung adenocarcinoma cells. Cell Tissue Res. 300:2000;57-65.
23. Imai Y., Shiratori Y., Kato N., Inoue T., Omata M. Mutation inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1 is rare in sporadic digestive tract cancers. Jpn J. Cancer Res. 90:1999;837-840.